Comments to FDA: Draft Guidance on New Dietary Ingredient Notification

Share page:
Docket Number:
FDA-2011-D-0376

The industry favors and supports the development of reasonable guidance. However, the agency’s attempt to redefine the NDI notification process contradicts the letter and spirit of DSHEA. The Draft Guidance would undo nearly two decades of agency practice and policy.

Related Posts

Weight Loss Products

OTC Sales Tax Exemptions